Table 3

 Analysis of anti-Saccharomyces cerevisiae antibodies (ASCA) in twins classified with Crohn’s disease (CD) in multivariate categories (stratification for location and behaviour)

CategorynAdjusted mean (95% CI) of ASCA (U/ml)Ratio (95% CI) of ASCA for CD v healthy twin sibling; p value
CD, Crohn’s disease; non-strict non-penetr, non-stricturing non-penetrating; strict/penetr, stricturing or penetrating; HT CD, healthy twin sibling to twin with Crohn’s disease.
Adjusted mean values of ASCA and ratios of ASCA mean between CD categories and healthy twins (reference category).
95% CI, 95% confidence intervals as well as parameter estimates.
CD, colonic (L2), non-strict non-penetr (B1)144.8 (−2.6–12.2)0.9 (0.6–1.5); p = 0.73
CD, colonic (L2), strict/penetr (B2/3)717.1 (8.1–26.2)2.2 (1.2–4.1); p = 0.008
CD, small bowel (L1, 3, 4), non-strict non-penetr (B1)1616.0 (9.8–22.1)2.2 (1.4–3.4); p = 0.004
CD, small Bowel (L1, 3, 4), strict/penetr (B2/3)3319.3 (15.0–23.6)3.2 (2.4–4.4); p<0.0001
HT CD475.2 (3.2–7.2)1.0 (reference)